Healthcare Leveraged Lending
Oxford Finance’s dedicated team of specialized leveraged lending professionals understand our clients’ industries and construct financial solutions to meet our clients’ needs now and in the future. A member of our team serves as our clients’ single point of contact throughout the deal lifecycle.
Sector Expertise
Our experience ranges across many healthcare-related sub-sectors including, but not limited to:
Physician & Dental Practice Management
Hospitals, Outpatient Surgery & Other Facility-Based Centers
Home Health, Hospice & Other Ancillary Providers
Behavioral Health
Revenue Cycle Management & Healthcare Business Services
Healthcare Staffing Services
Investment Criteria
Oxford invests primarily in lower middle-market healthcare services businesses with the following characteristics:
Target Transactions
- Sponsored & Non-Sponsored
- EBITDA: $5MM to $30MM
- Hold Size: $20MM to $200MM Per Deal
- U.S. — Nationwide
- Lead Arranger or Club Participant
Products & Services
- Revolvers
- Senior & Unitranche Term Loans
- Delayed Draw Term Loans (DDTL)
- 2nd Lien / Last-Out / Mezzanine
- Split-Collateral
Transaction Types
- Buyouts
- Leveraged Recapitalizations
- Growth / Acquisitions
- Refinancing
Recent Transactions
$8,000,000
Term Loan & Revolver
Sole Lender
Michigan
Undisclosed Amount
Term Loan, Revolver, & DDTL
Sole Lead Arranger & Administrative Agent
A Portfolio Company of:
$66,900,000
Term Loan
Sole Lender
Louisiana
$13,500,000
Term Loan
Sole Lender
Wisconsin
-
I have a long track record with Oxford, and have found them very easy to work with and competitively priced. They know the life sciences space, and have the flexibility and patience needed to support start-ups through the various stages of development.
Richard Buchholz
Chief Financial Officer, Inspire Medical Systems -
Oxford has been in the life sciences field for a long time, and they have a thorough understanding of companies in this space. They understand business risks and that projections and final numbers may differ. The funds we received from Oxford enabled us to extend our runway at a minimal cost of capital dilution.
Kevin Cousins
Vice President & Chief Financial Officer, Sequent Medical -
Oxford Finance is one of the premier venture lending groups serving the life sciences community. Their continuity in the marketplace, as well as their professional and collaborative approach to transactions, makes them a logical go-to source for CFOs.
John Schmid
Chief Financial Officer, Auspex Pharmaceuticals -
Oxford’s greatest asset is its team. They have deep industry knowledge that allows them to think and act strategically with their clients, and to do so in a timely manner. They also care about relationship building, and that has greatly enhanced our ability to work well together.
Peter Lawrence
President & COO, ArQule, Inc.
